Financials
Financial year 2026
Worth noting
- Little cash and receivables against the short-term debts.
Revenue
€ 51.4 million
▲ 28% vs 2025
Profit
Caution€ -2.7 million
▼ 153% vs 2025
Debts
Low€ 36.1 million
▼ 12% vs 2025
FUJIREBIO EUROPE from Gent, company number BE0427550660, closed financial year 2026 with a result of € -2.7 million after tax. For that financial year FUJIREBIO EUROPE recorded revenue of € 51.4 million and equity of € 45.7 million. Compared with financial year 2025, the result moved from € 5.2 million to € -2.7 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.
What happened at FUJIREBIO EUROPE?
What happened at FUJIREBIO EUROPE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: loss of € 2.7 million (▼ 153% vs 2025). Source: NBB ↗
- TADASHI NINOMIYA stepped down as director. NBB
- KURT TROCH stepped down as director. NBB
- AOKI KOJI stepped down as director. NBB
- CDW Invest BV stepped down as director. NBB
- GOKI ISHIKAWA stepped down as director. NBB
- TADASHI NINOMIYA became a director. NBB
- KURT TROCH became a director. NBB
In short
From € 1.8 million loss in 2023 to € 2.7 million loss in 2026.
Paid € 1.2 million in corporate taxes since 2023.
Best year ever: 2025, with € 5.2 million profit.
Pays suppliers within 134 days on average.
A new publication or filing at FUJIREBIO EUROPE? We notify you, reason included.
Follow FUJIREBIO EUROPENeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 100% of Fujirebio Iberia SL, 100% of Fujirebio Germany GmbH, 100% of ADx NeuroSciences NV, 100% of Fujirebio France SARL and 100% of Fujirebio Italia S.r.l. itself.
Directors
According to the 2026 annual accounts
GOKI ISHIKAWA
Director
since 2014 · until 2026
TADASHI NINOMIYA
Director
since 2026 · until 2026
KURT TROCH
Director
since 2022 · until 2026
AOKI KOJI
Director
since 2022 · until 2026
Managing director · represented by Christiaan De Wilde
Also active at: ADx NeuroSciences
since 2022 · until 2026
Establishments
Establishment units
Physical locations of this company
Technologiepark-Zwijnaarde 6
9052 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
Details
- Company number
- 0427.550.660
- VAT number
- BE 0427.550.660
- Registered office
- Technologiepark-Zwijnaarde 6, 9052 Gent
- Names & denominations
- FUJIREBIO EUROPE
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 18 July 1985
- Peppol
- Active · Active since 8 Jan 2026
- Activities · NACE
Vervaardiging van andere chemische producten, neg
Vervaardiging van overige chemische producten
Speur- en ontwikkelingswerk op biotechnologisch gebied